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Objective: To observe the chitooligosaccharides (COS) effect on the proliferation
inhibition and radiosensitivity of three types of human gastric cancer cell line.
Mothods: CCK-8 assay was employed to obtain the inhibition ratio of COS on BGC823
cells, MKN45 cells and SGC7901 cells at 48 h after treatment and the proliferation-
inhibition curve was drawn with the inhibition ratio of COS on three types of cells.
The clonogenic assay was used to detect the cell viability of 0, 1, 2, 4, 6 and 8 Gy (6 dose
grades) in RAY group and RAY + COS group after X-ray, and the cell survival curve was
used to analyze the sensitization enhancement ratio of COS. Flow cytometry was
employed to detect cell cycle and apoptosis rate in control group, RAY group and
RAY + COS group after 48 h treatment.
Results: COS inhibited the proliferation of three types of cells. The inhibition rate was
positively correlated with the concentration of COS, and the susceptibility of MKN45
cells, SGC7901 cells and BGC823 cells to COS decreased in turn. The cell viability
decreased gradually with the increasing radiation dose in RAY group and RAY + COS
group (P < 0.01). The cell viabilities of RAY + COS group were lower than those of
RAY group at all the dose grades under X-ray exposure (P < 0.01), and the sensitization
enhancement ratios of COS on BGC823 cells, MKN45 cells and SGC7901 cells were
1.06, 1.28 and 1.15, respectively. In controlled trials, apoptosis rate and percentage in the
G2/M phase of three types of cells in RAY + COS group were higher than those in control
group and RAY group, and percentage in the S phase and the G0/G1 phase in
RAY + COS group were lower than those in the other two groups (P < 0.01).
Conclusions: COS can inhibit the proliferation of three types of human gastric cancer
cells and enhance the radiosensitivity by inducing apoptosis and G2/M phase arrest.1. Introduction
With the progress of medical science and technology, the
incidence and mortality of gastric cancer show a trend of decline
gradually in the worldwide, but China is still a high-risk area
where the cases of newly-increased and death in each year are
more than 40% and 35% of total amount of the world [1]. A
survey data of cancer epidemiology of China in 2010 showed
that standardized incidence and mortality of gastric cancer allranked third in malignant tumor, 23.71% and 16.64%
respectively [2,3], and it's of great signiﬁcance to actively
explore the effective treatment for many patients with gastric
cancer. Although surgical resection is still the preferred way to
radically cure gastric cancer currently, the recurrence and
mortality of a single surgery are more than 80% in 5 years
after operation. Based on this background, radiotherapy as an
irreplaceable and important supplementary method has been
used in each stage of clinical treatment comprehensively [4,5].
Although radiotherapy shows more and more advantages in the
treatment and research of gastric cancer, damage of radioactive
rays on healthy tissue still can't be ignored. The use of
excellent radiosensitizer is effective measure to lower the side-
effect of radiotherapy. Chitooligosaccharides (COS) is one of
the concerned hot-topics of biological medical workers in recent
years and past research has found that it not only possesses ther the CC BY-NC-ND license (http://
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mune, but also has positive effect to inhibit tumor development
[6,7]. However, the use of COS synergistic radiation is still
seldom reported so far. This research selects three types of
human gastric cancer cell line including BGC823, MKN45 and
SGC7901 as objective to conduct an experiment to compare
COS effect on their proliferation inhibition and
radiosensitization. Moreover, we preliminary explore the
mechanism of action and hope to provide theoretical basis for
seeking more efﬁcient and harmfulless treatment scheme for
gastric cancer. Presently reports are the following.
2. Materials and methods
2.1. Cell lines, experimental materials and experimental
methods
A total of 6 concentration levels of COS were established
and each level was conducted simultaneously with 3 holes in
parallel samples. Three cell lines of continuous cell culture to
logarithmic phase (human gastric cancer including BGC823,
MKN45, SGC7901 cells, Shanghai Institute of Cells, Chinese
Academy of Sciences) were diluted as 4 × 104/L of concen-
tration through digestion and joined into 96-well plates ac-
cording to 0.1 mL/well, and then were placed in a suitable
environment for adherent growth (CO2 incubator, Shanghai
Gemtop Scientiﬁc Instrument Co., LTD). The fresh culture
medium (0.11 mL/well) diluted with COS (Shanghai HuiCheng
Biotechnology Co., LTD) was replaced after 24 h and 0, 1.0,
2.0, 3.0, 4.0, 5.0 mg/mL of concentrations respectively were
added into COS in each well. After inﬁltrating 48 h, CCK-8
reagent was added into COS along the well (0.01 mL/well)
(CCK-8 kit, Shanghai LiRui Biological Technology co., LTD),
and then the reagent and culture solution were mixed by tap-
ping culture plate. All levels of absorbance (OD) were detected
at l = 450 nm in 4 h after reacting fully. The experiment was
repeated for 3 times to investigate the proliferation suppression
effect of COS on three types of cells, which is the basis to
select 1.0 mg/mL of COS concentration to conduct a follow-up
study.
A total of 6 dose levels of X-ray were established, and each
level was divided into RAY group and RAY + COS group and
each group was conducted simultaneously with 3 holes in par-
allel samples. Different concentrations of single-cell suspension
were joined into 6 wells culture plate according to the inoculation
amount of 0 Gy dose level (200/well), 1, 2 Gy dose level (500/
well), 4, 6 Gy dose level (2000/well) and 8 Gy dose level (5000/
well), and were placed in a suitable environment for adherentTable 1
Anti-proliferative effect of COS on three types of cells.
COS concentration
(mg/mL)
BGC823 MK
OD Inhibition rate (%) OD I
0 0.983 ± 0.012 0.00 0.993 ± 0.010
1.0 0.929 ± 0.019 5.49 0.895 ± 0.013
2.0 0.851 ± 0.015 13.43 0.797 ± 0.031
3.0 0.755 ± 0.023 23.19 0.687 ± 0.025
4.0 0.645 ± 0.011 34.38 0.566 ± 0.015
5.0 0.521 ± 0.019 47.00 0.425 ± 0.024
F 304.6 – 352.8
PANOVA 0.000 – 0.000growth. Appropriate COS (1.0 mg/mL) was added into each well
of RAY + COS group after 6 h and equivalent quantity of culture
medium was added into each well of RAY group after inﬁltrating
for 48 h. Tissue analog with about 1 cm thickness was afﬁxed on
the culture plates in two groups and was conducted with X-ray
irradiation in a distance of 100 cm and dosage rate of 2 Gy/min.
(electron linear accelerator, Nanjing Chuang Rui Ying Biological
Technology Co., LTD). Culturing for 12 d continuously, the
number of cell mass consisted over 50 U was calculated through
washing, ﬁxing and dyeing. The experiment was repeated for 3
times to calculate data and draw up the cell survival curve, and
sensitization enhancement ratio was calculated by the value of
ﬁnal slope (D0): SER = D0(RAY)/D0(RAY + COS).
Three groups were established and conducted simultaneously
with 3 holes in parallel samples. The cell suspension of 1 × 105/
L concentration was inoculated into 6-well plates and was
placed in a suitable environment for adherent growth for 24 h.
Appropriate COS (1.0 mg/mL) was added into RAY + COS
group and equivalent quantity of culture medium was added into
non-treatment group and RAY group. RAY group and
RAY + COS group were inﬁltrated for 48 h, and then received
6 Gy X-ray irradiation. Cultivating 48 h after replacing fresh
medium, cell cycle and apoptosis rate in all groups were detected
through the processing of digestion, wash and dilution.
2.2. Statistical methods
SPSS19.0 statistical software was used to perform statistical
analysis. The distribution ratio of OD value, survival rate,
apoptosis rate and cell cycle were all expressed as mean ± SD.
ANOVA was used to analyze the OD value of various COS
concentration levels and cell survival rate of X-ray dose levels
among many groups. T-test was used to compare the cell sur-
vival rate under all X-ray doses of RAY group and RAY + COS
group, and cell cycle and apoptosis rate in the third group of
control group. P < 0.05 showed statistical signiﬁcance.
3. Results
3.1. Anti-proliferative effect of COS on BGC823 cells,
MKN45 cells and SGC7901 cells
OD values of BGC823 cells, MKN45 cells and SGC7901
cells under COS concentrations (0 mg/mL) were used as refer-
ence standard. The cell survival rate of three types of cells was
decreased with a higher concentration of inﬁltrating after
disposing various COS concentrations for 48 h and the differ-
ence was statistically signiﬁcant (P < 0.01). The COS wasN45 SGC7901 P F
nhibition rate (%) OD Inhibition rate (%)
0.00 0.984 ± 0.008 0.00 0.074 2.09
8.95 0.910 ± 0.016 7.52 0.040 6.95
18.92 0.820 ± 0.023 16.67 0.003 60.7
30.82 0.715 ± 0.017 27.34 0.000 156.2
43.00 0.596 ± 0.018 39.43 0.000 198.5
57.20 0.478 ± 0.024 51.42 0.000 263.4
– 337.1 – – –
– 0.000 – – –
Table 2
Comparison of cell survival rate of three types of cells under different radiation doses in RAY group and RAY + COS group.
Radiation doses (Gy) BGC823 MKN45 SGC7901
RAY RAY + COS RAY RAY + COS RAY RAY + COS
0 98.92 ± 2.53 99.04 ± 2.81 99.11 ± 2.15 99.02 ± 2.26 98.76 ± 3.04 98.89 ± 2.87
1 91.59 ± 2.18 88.22 ± 2.33# 91.24 ± 3.10 86.50 ± 2.79# 91.52 ± 2.82 87.35 ± 3.15#
2 67.82 ± 3.02 63.75 ± 2.75# 75.65 ± 3.28 58.41 ± 3.09# 72.34 ± 3.45 63.83 ± 2.95#
4 42.16 ± 2.62 35.21 ± 2.90# 48.95 ± 2.77 33.04 ± 2.46# 45.91 ± 3.41 35.08 ± 2.76#
6 19.59 ± 2.31 15.38 ± 1.79# 26.41 ± 2.14 15.63 ± 2.53# 22.50 ± 2.20 15.07 ± 2.03#
8 6.16 ± 0.86 5.02 ± 0.78# 9.55 ± 1.64 4.89 ± 1.57# 8.75 ± 1.75 5.39 ± 1.16#
F 137.1 204.1 167.8 256.8 149.5 237.0
P 0.000 0.000 0.000 0.000 0.000 0.000
Compared with RAY group: #P < 0.01.
Table 3
Comparison of apoptosis rate of three types of cells in each group (%).
Group BGC823 MKN45 SGC7901
Non-treatment group 1.94 ± 0.44 2.27 ± 0.48 2.03 ± 0.51
RAY group 8.37 ± 1.33# 8.96 ± 1.35# 8.64 ± 1.21#
RAY + COS group 15.37 ± 1.16#* 21.54 ± 1.77#* 19.08 ± 1.52#*
Compared with non-treatment group: #P < 0.01; compared with RAY
group: *P < 0.01.
Figure 1. Comparison of cell apoptosis condition of three types of cells in
each group.
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centration of treatment of three types of cells. The cell survivalTable 4
Comparison of cell cycle distribution of BGC823, MKN45 and SGC7901
cells in three groups (%).
Groups S G0/G1 G2/M
BGC823
Non-treatment group 36.42 ± 1.07 30.89 ± 0.96 32.69 ± 0.88
RAY group 33.56 ± 0.84# 26.03 ± 0.68# 40.41 ± 0.91#
RAY + COS group 27.51 ± 0.77#* 21.64 ± 0.52#* 50.85 ± 1.13#*
MKN45
Non-treatment group 30.15 ± 0.82 39.41 ± 1.05 30.44 ± 0.68
RAY group 22.48 ± 0.74# 30.51 ± 0.86# 47.01 ± 0.52#
RAY + COS group 18.89 ± 0.65#* 24.34 ± 0.46#* 56.77 ± 0.28#*
SGC7901
Non-treatment group 36.15 ± 0.88 38.48 ± 1.00 25.37 ± 0.75
RAY group 31.66 ± 0.93# 31.90 ± 0.97# 36.44 ± 0.61#
RAY + COS group 26.08 ± 0.81#* 26.34 ± 0.59#* 47.58 ± 0.43#*
Compared with non-treatment group: #P < 0.01; compared with RAY
group: *P < 0.01.rate of three types of cells also showed signiﬁcant difference
among groups after treatment with COS of various concentration
levels. COS showed the stronger suppression effect on MKN45
followed by SGC7901 and showed the minimum effect on
BGC823. The difference of 1.0 mg/mL COS concentration level
comparison was statistically signiﬁcant (P < 0.05). OD values
comparison in three groups has signiﬁcant statistical difference
(P < 0.01) when COS concentration increased to 2.0, 3.0, 4.0
and 5.0 mg/mL (Table 1).
3.2. Comparison of the cell survival rate of different
dose levels of irradiation among groups
Survival rates of BGC823 cells, MKN45 cells and SGC7901
cells under 0 Gy dose of irradiation were used as reference
standard. The survival rate of three types of cells in RAY group
and RAY + COS group was decreased with enlargement of dose
of irradiation and the difference was statistically signiﬁcant
(P < 0.01) and the amplitude of RAY + COS group was greater.
The cell survival rate of RAY + COS group was signiﬁcant
lower as the doses were 1, 2, 4, 6 and 8 Gy and the difference
was statistically signiﬁcant (P < 0.01). The sensitization
enhancement ratios of COS on BGC823 cells, MKN45 cells and
SGC7901 cells were 1.06, 1.28 and 1.15 respectively obtained
by drawing radiation survival curve of three types of cells
(Table 2).
3.3. Comparison of apoptosis rate between groups
Observing three types of cells respectively, the apoptosis
rates of RAY group and RAY + COS group were all more
stimulating and increasing than non-treatment group, which had
signiﬁcant difference (P < 0.01) and the apoptosis rate of
RAY + COS group increased signiﬁcantly than that in RAY
group, which had signiﬁcant difference (P < 0.01) (Table 3 and
Figure 1).
3.4. Comparison of cell cycle distributions between
groups
Observing three types of cells respectively, G2/M phase
proportion of RAY group and RAY + COS group was signiﬁ-
cant elevated than non-treatment group and the percentage of S
phase and G0/G1 phase was reduced, which was signiﬁcant
difference (P < 0.01). The percentages of S phase and G0/G1
phase of RAY + COS group were smaller and the duration of
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difference (P < 0.01) (Table 4).
4. Discussion
Modern unhealthy eating habit and onerous pressure of life
are all the high-risk factors to cause frequent gastric cancer. The
morbidity and mortality of gastric cancer has reached 29.9/
100000 and 22.3/100000 respectively in 2010 year of our
country and the number of death has been accounted for 23.3%
of the death toll due to the cancer [8,9]. Therefore, it is urgent and
meaningful to seek efﬁcient and feasible drugs and treatment
methods against gastric cancer.
COS is the outstanding outcome of development of sugar
biology and its all aspects like water solubility, absorptivity and
afﬁnity of human body have a unique advantage on high mo-
lecular sugars. Hence, COS is the one of foci of investigators on
biological medicine. The research has veriﬁed the anti-tumor
effect of COS on the leucocythemia, breast cancer and bladder
cancer and scholars believed that its mechanism involved in
multiple approaches [7,10,11]. In this research, COS also revealed
the general proliferation inhibitory effect on human gastric
cancer cells (BGC823, MKN45 and SGC7901) and the growth
inhibiting rate of three types of cells was positively correlated
with COS concentration. At the same time, we also found that
the three types of cells showed sensitivity difference against
the effect of growth retardation of COS (MKN45 is the
strongest, followed by SGC7901 and BGC823) and the
different outcome still needs further study.
Previous theory showed that gastric cancer cells have a
strong resistance on radioactive rays, while the surrounding or-
gans are easily suffered collateral damage. Hence, radiotherapy
is not recommended to use in therapeutic schedule of gastric
cancer [12]. However, with the rapidly development of
positioning technology of computer and widespread use of
radiosensitizer, radiotherapy nowadays has already occupied
irreplaceable important position in the treatment of gastric
cancer, which was used as assisted surgery to achieve the aim
of reducing difﬁculty in the removal and the local recurrence,
and prolonging the survival time [13,14]. For enhancing the
effect of radiotherapy and protecting healthy tissue escaped
from collateral damage of radioactive rays simultaneously,
researchers are always seeking the efﬁcient and reliable
radiosensitizer. In this research, the survival rates of three
types of human gastric cancer cells in RAY group and
RAY + COS group were sharply reduced with the increasing
of radiological dose. The combined application of COS and
X-ray signiﬁcantly elevated the killing effect. The COS
promoted radiosensitivity of BGC823 cells, MKN45 cells and
SGC7901 cells (1.06, 1.28 and 1.15, respectively).
Further control experiment showed that the synergistic effect
of radiotherapy of COS on the three types of cells was correlated
with surging of apoptosis rate. The apoptosis rates of three types
of cells (BGC823, MKN45 and SGC7901) in RAY + COS
group were more elevated than RAY group (1.84, 2.21 and
2.40). Apoptosis is an autologous dominant order-maintenance
mechanism of organism to maintain its steady state operation
and to realize the self-elimination of old, weak and sick cells and
to save resources and earn a more favorable survival condition
for organism. Apoptosis is one of the critical pathways in
inducing normal cell death. It is inseparable between unlimited
breeding cycle of cancer cells and regulating the disorder ofautologous apoptosis process. The study of Tan and Mates et al.
respectively reported that COS involved by different approaches
can promote the apoptosis of cancer cells, such as disrupting
physiological potential difference of mitochondrial membrane,
releasing cytC into endochylema or reducing the environment of
GSH activity and stimulating the peroxidation damage [15,16],
which speculate that COS possess the gain effect on the
apoptosis of cancer cells induced by radioactive rays.
Nowadays, the cell cycle sub-distribution is one of the heated
topics of radiation biology research. The results of this research
showed that COS can stimulate the deviation of cycle phase
distribution of three types of human gastric cancer cells at the
same time. The proportion of G2/M phase was signiﬁcantly
increased and the proportions of G0/G1 phase and S phase were
relatively lower. G2/M phase showed the strongest response on
irradiation injury, while G1 phase and S phase will greatly
reduce the duration of DNA damage and repair [17,18]. The
change of cell cycle distribution will signiﬁcantly reduce the
defense capability of cancer cells against X-ray and is helpful
to improve the efﬁcacy of radiotherapy. The operation of cell
cycle process is according to a series of perfect and rigorous
procedural evolution. Nowadays, the known regulating and
control mediums are mainly including three major types
(cyclin, CDK and CKI), which transform as the interaction
and common manipulation of all factors, while the acting site
of COS proliferation cycle distribution is still unknown [19,20].
In conclusion, COS possesses general growth retardation and
radiosensitizing effect on three types of human gastric cancer
and SER of MKN45, SGC7901 and BGC823 cells were 1.06,
1.28 and 1.15. The combined application of COS and radio-
therapy can induce the increase sharply of apoptosis rate of
cancer cells and the deviation of cycle phase distribution.
Further research on anti-tumor effect of COS is conducted to
open a window of hope for many patients with gastric cancer.
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